Survivin is a novel target of CD44-promoted breast tumor invasion

Mohamed E. Abdraboh, Rajiv L. Gaur, Andrew D. Hollenbach, Dane Sandquist, Madhwa H G Raj, Allal Ouhtit

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The hyaluronan (HA) receptor CD44 plays an essential role in cellcell or cellextracellular matrix communications and is a bioactive signal transmitter. Although a number of studies have described the function of CD44 in breast cancer (BC) metastasis, the underlying mechanisms have yet to be determined. By using a validated tetracycline-off-regulated CD44 expression system in the MCF-7 cell line combined with microarray analysis, we identified survivin (SVV) as a potential downstream transcriptional target of CD44. To test the hypothesis that SVV underpins CD44-promoted BC cell invasion, we combined molecular and pharmacologic approaches and showed that CD44 induction increased SVV expression levels, which in turn promotes BC cell invasion. Further, clinical analysis of breast tissue samples showed that SVV expression patterns paralleled those of the standard form of CD44 during breast tumor progression. More interestingly, we identified the PI3K/E2F1 pathway as a potential molecular link between HA/CD44 activation and SVV transcription. In addition to identifying SVV as a target for HA/CD44 signaling, this investigation provides a better understanding of the molecular mechanisms that underpin the novel function of SVV in breast cancer metastasis.

Original languageEnglish
Pages (from-to)555-563
Number of pages9
JournalAmerican Journal of Pathology
Volume179
Issue number2
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Breast Neoplasms
Hyaluronic Acid
CD44 Antigens
Neoplasm Metastasis
MCF-7 Cells
Microarray Analysis
Tetracycline
Phosphatidylinositol 3-Kinases
Transcriptional Activation
Breast
Cell Line

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Abdraboh, M. E., Gaur, R. L., Hollenbach, A. D., Sandquist, D., Raj, M. H. G., & Ouhtit, A. (2011). Survivin is a novel target of CD44-promoted breast tumor invasion. American Journal of Pathology, 179(2), 555-563. https://doi.org/10.1016/j.ajpath.2011.04.042

Survivin is a novel target of CD44-promoted breast tumor invasion. / Abdraboh, Mohamed E.; Gaur, Rajiv L.; Hollenbach, Andrew D.; Sandquist, Dane; Raj, Madhwa H G; Ouhtit, Allal.

In: American Journal of Pathology, Vol. 179, No. 2, 08.2011, p. 555-563.

Research output: Contribution to journalArticle

Abdraboh, ME, Gaur, RL, Hollenbach, AD, Sandquist, D, Raj, MHG & Ouhtit, A 2011, 'Survivin is a novel target of CD44-promoted breast tumor invasion', American Journal of Pathology, vol. 179, no. 2, pp. 555-563. https://doi.org/10.1016/j.ajpath.2011.04.042
Abdraboh ME, Gaur RL, Hollenbach AD, Sandquist D, Raj MHG, Ouhtit A. Survivin is a novel target of CD44-promoted breast tumor invasion. American Journal of Pathology. 2011 Aug;179(2):555-563. https://doi.org/10.1016/j.ajpath.2011.04.042
Abdraboh, Mohamed E. ; Gaur, Rajiv L. ; Hollenbach, Andrew D. ; Sandquist, Dane ; Raj, Madhwa H G ; Ouhtit, Allal. / Survivin is a novel target of CD44-promoted breast tumor invasion. In: American Journal of Pathology. 2011 ; Vol. 179, No. 2. pp. 555-563.
@article{af0950f970154bc8a616297cd51aa5a7,
title = "Survivin is a novel target of CD44-promoted breast tumor invasion",
abstract = "The hyaluronan (HA) receptor CD44 plays an essential role in cellcell or cellextracellular matrix communications and is a bioactive signal transmitter. Although a number of studies have described the function of CD44 in breast cancer (BC) metastasis, the underlying mechanisms have yet to be determined. By using a validated tetracycline-off-regulated CD44 expression system in the MCF-7 cell line combined with microarray analysis, we identified survivin (SVV) as a potential downstream transcriptional target of CD44. To test the hypothesis that SVV underpins CD44-promoted BC cell invasion, we combined molecular and pharmacologic approaches and showed that CD44 induction increased SVV expression levels, which in turn promotes BC cell invasion. Further, clinical analysis of breast tissue samples showed that SVV expression patterns paralleled those of the standard form of CD44 during breast tumor progression. More interestingly, we identified the PI3K/E2F1 pathway as a potential molecular link between HA/CD44 activation and SVV transcription. In addition to identifying SVV as a target for HA/CD44 signaling, this investigation provides a better understanding of the molecular mechanisms that underpin the novel function of SVV in breast cancer metastasis.",
author = "Abdraboh, {Mohamed E.} and Gaur, {Rajiv L.} and Hollenbach, {Andrew D.} and Dane Sandquist and Raj, {Madhwa H G} and Allal Ouhtit",
year = "2011",
month = "8",
doi = "10.1016/j.ajpath.2011.04.042",
language = "English",
volume = "179",
pages = "555--563",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Survivin is a novel target of CD44-promoted breast tumor invasion

AU - Abdraboh, Mohamed E.

AU - Gaur, Rajiv L.

AU - Hollenbach, Andrew D.

AU - Sandquist, Dane

AU - Raj, Madhwa H G

AU - Ouhtit, Allal

PY - 2011/8

Y1 - 2011/8

N2 - The hyaluronan (HA) receptor CD44 plays an essential role in cellcell or cellextracellular matrix communications and is a bioactive signal transmitter. Although a number of studies have described the function of CD44 in breast cancer (BC) metastasis, the underlying mechanisms have yet to be determined. By using a validated tetracycline-off-regulated CD44 expression system in the MCF-7 cell line combined with microarray analysis, we identified survivin (SVV) as a potential downstream transcriptional target of CD44. To test the hypothesis that SVV underpins CD44-promoted BC cell invasion, we combined molecular and pharmacologic approaches and showed that CD44 induction increased SVV expression levels, which in turn promotes BC cell invasion. Further, clinical analysis of breast tissue samples showed that SVV expression patterns paralleled those of the standard form of CD44 during breast tumor progression. More interestingly, we identified the PI3K/E2F1 pathway as a potential molecular link between HA/CD44 activation and SVV transcription. In addition to identifying SVV as a target for HA/CD44 signaling, this investigation provides a better understanding of the molecular mechanisms that underpin the novel function of SVV in breast cancer metastasis.

AB - The hyaluronan (HA) receptor CD44 plays an essential role in cellcell or cellextracellular matrix communications and is a bioactive signal transmitter. Although a number of studies have described the function of CD44 in breast cancer (BC) metastasis, the underlying mechanisms have yet to be determined. By using a validated tetracycline-off-regulated CD44 expression system in the MCF-7 cell line combined with microarray analysis, we identified survivin (SVV) as a potential downstream transcriptional target of CD44. To test the hypothesis that SVV underpins CD44-promoted BC cell invasion, we combined molecular and pharmacologic approaches and showed that CD44 induction increased SVV expression levels, which in turn promotes BC cell invasion. Further, clinical analysis of breast tissue samples showed that SVV expression patterns paralleled those of the standard form of CD44 during breast tumor progression. More interestingly, we identified the PI3K/E2F1 pathway as a potential molecular link between HA/CD44 activation and SVV transcription. In addition to identifying SVV as a target for HA/CD44 signaling, this investigation provides a better understanding of the molecular mechanisms that underpin the novel function of SVV in breast cancer metastasis.

UR - http://www.scopus.com/inward/record.url?scp=80052473361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052473361&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2011.04.042

DO - 10.1016/j.ajpath.2011.04.042

M3 - Article

C2 - 21718681

AN - SCOPUS:80052473361

VL - 179

SP - 555

EP - 563

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 2

ER -